News

• Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
  11/21/2019 / 15:02 - GlobeNewswire
•  
• RWE posts net income of €9B in first three quarters
  11/14/2019 / 07:10 - TeleTrader
•  
• RWE reaches 57-month high after selling Innogy to E.ON
  09/20/2019 / 12:04 - TeleTrader
•  
• E.ON: Innogy concessions hurt profit outlook
  09/17/2019 / 12:51 - TeleTrader
•  
• EU accepts E.ON's remedies in Innogy deal
  09/17/2019 / 10:39 - TeleTrader
•  
• Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
  08/14/2019 / 12:00 - GlobeNewswire
•  
• RWE adj net income rises 34% to €914 million
  08/14/2019 / 07:09 - TeleTrader
•  
• RWE at over four-year high on improved outlook
  07/30/2019 / 12:06 - TeleTrader
•  
• DAX sinks over 1% to below 12,000 mark
  05/23/2019 / 13:35 - TeleTrader
•  
• RWE posts profit of €273M in Q1, up 250% YoY
  05/15/2019 / 07:14 - TeleTrader
•  
• $1.64 Bn Real World Evidence (RWE) Solutions Market by Component, Application, End User - Global Forecast to 2024
  03/27/2019 / 12:20 - GlobeNewswire
•  
• RWE posts profit of €591 million in fiscal 2018
  03/14/2019 / 07:18 - TeleTrader
•  
• RWE loses €0.11 per share in first three quarters
  11/14/2018 / 07:19 - TeleTrader
•  
• RWE posts EPS at €0.26 in H1, down 94% YoY
  08/14/2018 / 07:12 - TeleTrader
•  
• RWE revenue falls 7.3% to €11.6B in Q1
  05/15/2018 / 07:29 - TeleTrader